Navigation Links
Albemarle Raises Prices of Specialty Aluminas
Date:11/30/2007

Increase Includes Flame Retardants, Fillers, Pigments and Ceramic Oxides

BATON ROUGE, La., Nov. 30 /PRNewswire-FirstCall/ -- Albemarle Corporation (NYSE: ALB), the world leader in the development and marketing of aluminum trihydroxide and other specialty aluminas for flame retardants, fillers and other industrial applications, will increase the prices for all of its specialty aluminas up to 15 percent, effective globally on all shipment made on or after January 1, 2008, or as contracts allow. The increases are needed to help offset the rapidly escalating raw material prices, raw material freight costs and energy costs required to manufacture these products.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050801/ALBEMARLELOGO )

The price increases will take effect for all of the following products:

-- MARTINAL(R) aluminum trihydroxide (ATH) flame retardants

-- MARTIFIN(R) specialty alumina pigments

-- MARTOXID(R) aluminum oxide products

-- COMPALOX(R) activated aluminas

Plastics compounders and polymer manufacturers use Albemarle's MARTINAL flame retardants and technical services to add life-saving properties to wire & cable, roofing, flooring, pipe and other building and construction materials. MARTINAL fillers are also used to improve injection-molded plastic parts, insulating foams and certain electrical and electronic parts.

Albemarle's specialty ATH products are applied as pigmented fillers and coating minerals in the paper and board industry (MARTIFIN specialty pigments); as high-quality calcined aluminas for the industrial ceramics, refractory, and surface treatment industries (MARTOXID aluminum oxides); and as adsorbents and catalysts in chemical processes and environmental protection (COMPALOX activated aluminas).

Albemarle Corporation, headquartered in Richmond, Virginia, is a leading global developer, manufacturer and marketer of highly engineered specialty chemicals for consumer electronics; petroleum and petrochemical processing; transportation and industrial products; pharmaceuticals; agricultural products; and construction and packaging materials. The Company operates in three business segments-Polymer Additives, Catalysts and Fine Chemicals, and serves customers in approximately 100 countries. Learn more about Albemarle at http://www.albemarle.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Albemarle Corporation's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report on Form 10-K.


'/>"/>
SOURCE Albemarle Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Albemarle to Increase Price of Ibuprofen
2. Albemarle Reports Third Quarter 2007 Results
3. Albemarle to Raise Prices of Dibromomethane
4. BlueCare(R) Family Plan, a HUSKY Health Plan from Anthem Blue Cross and Blue Shield in Connecticut, Raises Awareness, Funds and Diapers for New Haven Diaper Bank
5. Nautica Malibu Triathlon Presented by Toyota Raises $718,000 for Childrens Hospital Los Angeles Pediatric Cancer Research
6. Fifth Annual Avon Walk for Breast Cancer Los Angeles Raises $4.3 Million
7. AHIP Praises Bipartisan Senate Vote on Mental Health Parity
8. Union President Praises Hillary Clintons Health Plan
9. Progression of SIV infection in monkeys raises
10. Computerized Jump Rope Raises Funds for Breast Cancer Research
11. AIDS Action Council Praises Release of Latest State of AIDS in Black America Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... The Justin Veatch Fund ... (NCADD) is recommending the film Whispering Spirits and its discussion guide for ... as an education tool in the war against teen drug abuse. NCADD is ...
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the ... advocacy groups, has aligned with Upstage Lung Cancer in efforts to combat lung cancer, ... Michael J. Hennessy, Jr said, “CURE Media Group is honored to team up with ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... 10.2 version gives development continuity to its innovative Unified Instance Manager architecture, ... capacity. In addition, this new version optimizes the unattended auto-dialing system without ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016 KEY FINDINGS ... of the market in 2016 and is expected to ... attributed to a large number of surgical procedures that ... largest share in the patient temperature management market.) Patient ... reducing loss of blood during surgeries, lowering the risks ...
(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...
(Date:12/8/2016)... 2016  Valeant Pharmaceuticals International, Inc. (NYSE: ... announced positive results from a Phase 3, multicenter ... safety and efficacy of IDP-118 (halobetasol propionate and ... Within the Phase 3 study ... psoriasis, IDP-118 showed statistical significance to vehicle with ...
Breaking Medicine Technology: